Skip to main content
SpringerLink
Log in

Adverse drug reactions during pregnancy

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Cahill A, Waterman B, Stamilio D, Odibo A, Allsworth J, Evanoff B, Macones G.Higher maximum dose of oxytocin are associated with an unacceptably high uterine rupture risk during VBAC. American Journal of Obstetrics and Gynecology 197 (Suppl.): 80, No. 6, Dec 2007

  2. Hayes E, Seligman N, Horowitz K, O'Neill M, Leiby B, Dysart K, Baxter J.Dose-response relationship between maternal methadone dose and decreased neonatal head circumference. American Journal of Obstetrics and Gynecology 197 (Suppl.): 81, No. 6, Dec 2007

  3. Murphy K, MACS Collaborative Group.Multiple courses of antenatal corticosteroids for preterm birth study. American Journal of Obstetrics and Gynecology 197 (Suppl.): 2, No. 6, Dec 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adverse drug reactions during pregnancy. React. Wkly. 1189, 5 (2008). https://doi.org/10.2165/00128415-200811890-00016

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200811890-00016

Keywords

Search

Navigation